SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061084
Filing Date
2023-11-08
Accepted
2023-11-08 16:05:10
Documents
16
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eq-20231106.htm   iXBRL 8-K 55839
2 EX-99.1 eq-ex99_1.htm EX-99.1 38657
3 EX-99.2 eq-ex99_2.htm EX-99.2 187162
4 GRAPHIC img162018617_0.jpg GRAPHIC 151895
5 GRAPHIC img162942138_0.jpg GRAPHIC 152548
  Complete submission text file 0000950170-23-061084.txt   844887

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eq-20231106_lab.xml EX-101.LAB 14899
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eq-20231106.xsd EX-101.SCH 2458
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eq-20231106_pre.xml EX-101.PRE 11392
10 EXTRACTED XBRL INSTANCE DOCUMENT eq-20231106_htm.xml XML 4882
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 231387739
SIC: 2834 Pharmaceutical Preparations